ONKOLYTISCHE VIRUSTHERAPIE

Patent europeic · EP3577132 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3577132
Numer da la dumonda
EP18747947
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
05-02-2018
Publitgà
11-12-2019
Concedì
06-05-2026
La protecziun finescha il pli tard
04-02-2038
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
C07K 14/47 (2006.01)
C07K 14/52 (2006.01)
C12N 7/01 (2006.01)
C12N 15/09 (2006.01)
Prioritad
US 201762454526 P 03.02.2017
Dumonda PCT
PCT/US2018/016912 05.02.2018
Publicaziun PCT
WO2018/145033 09.08.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 06-05-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 06.05.2026

Partidas

Inventur

GUO, Zong, Sheng

Wexford PA 15090, US

BARTLETT, David

Pittsburgh PA 15238, US

LIU, Zuqiang

Wexford PA 15090, US

FEIST, Mathilde

Pittsburgh PA 15260, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.